EVT:ETR
Evotec SE
€२.९६
arrow_upward
+१.४४%(+०.०४२) १ दि
५ ऑक्टो, ५:३५:०४ PM [GMT]+२ · EUR
search
सर्व सिम्बॉल
| सिम्बॉल | किंमत | बदल | % बदल |
|---|
insights_autoEVT साठी टॉप इनसाइट जनरेट करत आहे...
उघडा
€२.९१
उच्च
€३.००
कमी
€२.९०
मार्केट कॅप
५३.५१ कोटी
सरासरी उलाढाल
९.२१ लाख
उलाढाल
७.०६ लाख
५२ आठवड्यांतील उच्चांक
€७.३०
५२ आठवड्यांतील नीचांक
€२.७१
EPS
-€१.११
थकित शेअर
१७.७९ कोटी
कर्मचाऱ्यांची संख्या
४ ह
उघडा
€२.९१
उच्च
€३.००
कमी
€२.९०
मार्केट कॅप
५३.५१ कोटी
सरासरी उलाढाल
९.२१ लाख
उलाढाल
७.०६ लाख
५२ आठवड्यांतील उच्चांक
€७.३०
५२ आठवड्यांतील नीचांक
€२.७१
EPS
-€१.११
थकित शेअर
१७.७९ कोटी
कर्मचाऱ्यांची संख्या
४ ह
बातम्यांच्या स्टोरी
वेब स्रोत आणि बातमी भागीदारांकडून
AD HOC NEWS
·
६ तासांपूर्वी
Evotec stock after-hours at EUR 2.96: plus 1.02 percent after the Xetra close
AD HOC NEWS
·
१० तासांपूर्वी
Evotec loses research chief. Evotec stock gains 2.05 percent
AD HOC NEWS
·
११ तासांपूर्वी
Evotec stock reports weaker 2026 guidance ahead of results
AD HOC NEWS
·
२ दिवसांपूर्वी
Evotec announces science chief change. Evotec stock trades at EUR 2.93 versus EUR 2.93.
प्रोफाइल
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development.
The company's 4,200+ employees work across a number of therapeutic areas including CNS/neurology, metabolic diseases, Cancer, and inflammatory and infectious diseases. It has long-term discovery alliances with Bristol Myers Squibb, Bayer, Sanofi, Boehringer Ingelheim, the CHDI Foundation, Lilly, Takeda, Sernova, and more.
On 28 October 2009 the company was listed on the TecDAX index, which tracks the performance of the 30 largest German companies from the technology sector. On 24 September 2018 Evotec joined the MDAX index, following a rule change that enabled dual listing. The MDAX tracks 60 Prime Standard shares from sectors excluding technology. Wikipedia
Evotec SE बद्दल